reference/7498119

Predicate	Object
contentType	Journal Article\|Comment
endingPage	1006
issn	2215-0366
issueIdentifier	12
pageRange	1004-1006
publicationName	The lancet. Psychiatry
startingPage	1004
bibliographicCitation	Leucht S, Davis JM. What is the "best intro"-explanatory versus pragmatic antipsychotic drug trials. Lancet Psychiatry. 2020 Dec;7(12):1004–6. doi: 10.1016/s2215-0366(20)30436-3. PMID: 33069272.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95a876d55cb67e7c136cd1ff223b8b2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4af7f9c498cd279cfe4024bcb197bb7b
date	202012
identifier	https://pubmed.ncbi.nlm.nih.gov/33069272 https://doi.org/10.1016/s2215-0366%2820%2930436-3
isPartOf	https://portal.issn.org/resource/ISSN/2215-0366 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42935
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	What is the “best intro”—explanatory versus pragmatic antipsychotic drug trials
discusses	http://id.nlm.nih.gov/mesh/M0058773 http://id.nlm.nih.gov/mesh/M000602020 http://id.nlm.nih.gov/mesh/M0204623 http://id.nlm.nih.gov/mesh/M0021770
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014150Q000009 http://id.nlm.nih.gov/mesh/D012559Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000077582Q000627 http://id.nlm.nih.gov/mesh/D000077152Q000627 http://id.nlm.nih.gov/mesh/D000068180

Showing number of triples: 1 to 29 of 29.